Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Home
>
News
>
Rivaroxaban reduces adverse kidney events in atrial fibrillation patients with CKD
LATEST NEWS
Rivaroxaban reduces adverse kidney events in atrial fibrillation patients with CKD
Wellbutrin vs. Lexapro: Which Is Right For You?
Efficacy of three antimicrobial mouthwashes in reducing SARS
Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes
Extended Antidepressant Therapy Curbs Relapses in Bipolar Disorder
Rivaroxaban reduces adverse kidney events in atrial fibrillation patients with CKD
Aug 18, 2023
previous:
Prescribing DOACs with specific patient populations in mind
I’ve Never Been So Panicked in My Life: Adam’s Story
:next
Name:
*
E-mail:
*
Phone/WhatsApp:
*
Subject:
*
Content:
*
Send to us